fluoxetine + methylphenidate

Fluoxetine + methylphenidate is a combination of two pharmaceutical drugs used together, typically in the management of comorbid attention-deficit/hyperactivity disorder (ADHD) and depressive disorders. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant that increases synaptic serotonin levels by inhibiting its reuptake into presynaptic neurons. Methylphenidate is a central nervous system stimulant that primarily inhibits the reuptake of dopamine and norepinephrine, increasing their concentrations in the synaptic cleft. The combination may be prescribed when both ADHD and depression are present, but it requires careful monitoring due to potential pharmacokinetic interactions—fluoxetine can increase blood levels of methylphenidate and vice versa[1][2]. Clinical studies suggest this combination does not significantly increase adverse events compared to monotherapy in adults with ADHD and comorbid depression[3], though there are concerns about increased risk for side effects such as serotonin syndrome or cardiovascular complications[4]. Preclinical data indicate possible long-term neurobehavioral changes if used during adolescence[5].

Other names

Prozac + Ritalinfluoxetine hydrochloride + methylphenidate hydrochloride